World Renowned Speakers Announced at the 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

Focused on the pre-clinical, manufacturing, clinical and regulatory aspects of cell therapies and regenerative medicine, 4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress is taking place on 10-11 March 2020 in London – UK. The special impact would be laid on tissue engineering, Car-T cell-based immunotherapies, automated manufacturing, allogenic therapies with the aspects of hurdles in supply chain management and regulatory affairs.

The 2-day congress starting from March 10 to March 11, 2020 in London, will provide a platform to network with expert professionals from both industry and academia. Over the two days the speakers will present on key highlights – stem cell therapy and its application, culture technology for cell & gene therapy applications, autologous gene therapy delivery, conventional Car-T cell delivery and more.

The congress will see Ryan Guest from Immetacyte Ltd, Petter Björquist from Verigraft, Damian Marshall from Cell and Gene Therapy Catapult, Luca Crippa from Molmed, David Gilham from Celyad and more. Apart from these, the congress speaker line-up will host companies and universities such as AstraZeneca, Claris Ventures, Plasticell Limited, AMBR Consulting, University of Gothenburg, Aston University, Cardiff University and more.
The congress will also focus on 2 other important streams; manufacturing & commercialization of cellular therapies and Logistics, regulatory & investment.

You can view the conference overview, registration details and complete speaker list on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – or you can directly email on asking for more details, your queries and provide feedback.